Glutathione vs KPV

Look at the fill weights first. Glutathione ships at 1500mg. KPV ships at 10mg. A hundred and fifty times the mass, for $70 against $50. That gap is not a pricing quirk — it tells you almost everything about what these two compounds are and how they are used.

Proxiva Formulation DeskBlends, fill weights and multi-component products

The fill weight is the story

A 150-fold difference in supplied quantity between two compounds of identical chain length is not arbitrary. It reflects how each is used inside a cell.

Glutathione is a bulk constituent. Cells maintain it at millimolar concentrations — among the most abundant small molecules in the cytoplasm. It is not a signal; it is a working reagent, consumed and regenerated continuously as part of the cell's redox management. Research quantities follow: if the biology operates in bulk, so does the experiment.

KPV is a signal. Signalling molecules act by binding receptors, and receptor binding happens at concentrations orders of magnitude lower than bulk chemistry. Ten milligrams is a lot of a signalling peptide.

The per-milligram column is where the difference becomes stark — about a hundred-fold. Neither figure is wrong; they are simply measuring different kinds of thing.

Glutathione: everything turns on one sulfur atom

Glutathione is glutamate, cysteine and glycine. The cysteine is the whole point.

Cysteine carries a thiol group — a sulfur bonded to a hydrogen — and thiols are readily oxidised. That reactivity is not a defect; it is the function. Glutathione works by donating that hydrogen, neutralising reactive species and becoming oxidised itself in the process. Two oxidised molecules then join through a disulfide bridge to form GSSG, which the cell can reduce back.

So the compound exists in two forms — reduced (GSH) and oxidised (GSSG) — and only the reduced form does the work.

That makes oxidation the defining handling risk, and it is more acute here than for almost anything else in a catalogue. Most peptides degrade slowly through hydrolysis. Glutathione's active group is reactive by design, which means air exposure costs more, and the material can convert to its inactive form without any visible change.

There is also an unusual structural detail worth knowing: the glutamate is joined through its side-chain carboxyl rather than the usual backbone linkage. That gamma-linkage makes the molecule resistant to ordinary peptidases, which is part of why it survives in the cell at the concentrations it does.

Why the gamma-linkage matters more than it sounds

Glutathione has a structural oddity that explains why it survives inside a cell at concentrations no ordinary tripeptide could reach.

In every normal peptide, residues are joined backbone-to-backbone: the carboxyl group at the end of one amino acid bonds to the amino group of the next. That regular repeating linkage is exactly what peptidases evolved to recognise and cleave.

Glutathione's first bond is not built that way. The glutamate joins through its side-chain carboxyl rather than its backbone one — a gamma-linkage. Structurally it is still a peptide bond, but it sits in the wrong place for the standard machinery to grip.

The consequence is that ordinary peptidases cannot process it. Only one specialised enzyme handles that bond, which is why a molecule made of three common amino acids can persist at millimolar concentrations inside a cell rather than being dismantled within minutes.

This is the same design problem Semax and Selank solve with a proline tail, and Tesamorelin solves with an N-terminal modification — protect the molecule from the enzymes that would otherwise clear it. The difference is that evolution arrived at glutathione's solution and chemists arrived at the others.

For a buyer it means one fewer thing to worry about: glutathione is not fragile in the way short peptides usually are. Its vulnerability is entirely the thiol, and entirely about oxygen.

What that means when you buy it

One question matters more than the purity figure: what proportion is reduced?

A certificate reporting 99% purity has told you the material is 99% glutathione. It has not told you whether that glutathione is GSH or GSSG. Both are glutathione. Only one is active.

So for this compound specifically, look for the reduced-to-oxidised ratio, or at minimum a statement of which form is supplied. Its absence is a genuine gap — the equivalent of the missing copper figure on a GHK-Cu certificate, where the standard test also cannot see the thing that matters most.

• HPLC purity with the chromatogram image
• Mass-spectrometry identity
• Reduced vs oxidised form — the field specific to this compound
• Batch number matching the vial label
• Named testing laboratory, independent of synthesis
• Residual solvent panel
• Water and counterion content

KPV requires no equivalent extra field. Standard peptide documentation covers it — detail in how to read a certificate of analysis.

KPV: a fragment with a well-known parent

KPV is lysine, proline, valine — the final three residues of alpha-melanocyte-stimulating hormone. Its research context is inflammatory signalling.

The parent connects it to a compound most catalogues also stock. Alpha-MSH is what Melanotan II was designed to mimic, so both descend from the same hormone by opposite routes: Melanotan II is a cyclic analogue of the whole molecule, KPV a linear fragment of its tail.

They do entirely different things. The melanocortin receptor activity defining Melanotan II lives in a region KPV does not contain — a reminder that a fragment inherits whatever activity sits in the part retained, not the parent's reputation.

KPV also appears as a component of KLOW, alongside GHK-Cu, TB-500 and BPC-157. The near-identical GLOW blend is that same base without it, which makes the pair a clean comparison on what KPV contributes — worked through in GLOW versus KLOW.

Handling: the thiol sets the rules

One of these has a reactive group that is also its function. That changes what careful means.

Glutathione's cysteine carries a thiol, and thiols oxidise readily. The reaction is not a defect — donating that hydrogen is the work. But it means air exposure converts active material to inactive with no visible change whatsoever, and no certificate issued before the fact will tell you it happened.

So for glutathione: fewer draws, promptly resealed, and a preference for reconstituting small volumes rather than the whole vial. That matters more here than for a peptide whose failure mode is slow hydrolysis.

KPV has no equivalent liability. Three residues, no reactive side chain of note, ordinary discipline entirely sufficient.

Technique for both in reconstituting research peptides.

Frequently asked questions

Research use only. All products referenced on this page are sold strictly for laboratory and research purposes. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure, or prevent any disease. They are not for human or veterinary consumption. Handling should be performed only by qualified individuals in an appropriate laboratory setting.